Something that likely went under most peoples’ radar this past week was that the FDA announced the approval of a new drug for multiple sclerosis, Tecfidera, from Biogen Idec. That’s pretty good news for a disease that generally doesn’t have a lot of good news associated with it. Here’s some disease-progression data for it compared…
Early in my scientific career I was in a meeting to decide what one of our department’s new drug discovery projects was going to be. A team made a presentation on a prospective target, which was scientifically solid but was shot down because the potential market was too small. Not enough people had the disease,…
There was one piece of news that probably didn’t make many of your feeds this morning that is very important in my industry: today is the day the patent on Lipitor expires. I’m sure most of you are saying, “Huh?” or “So what?” or perhaps “Maybe now my prescription will cost less…”, but I look…
Stevil 